A development program for junior faculty, LAMP provides participants with critical tools to accomplish their primary career goals as academicians in the field of medicine.
The paper is a one-year retrospective review of the incidence of Clostridium difficile infection in NewYork-Presbyterian/Weill Cornell Medical Center inpatients.
This award is presented annually to members of the Weill Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research.
Fecal microbiota transplant has been shown in some studies to promote healing in the mucosal lining of the lower digestive tract, thus relieving ulcerative colitis symptoms in some people.
The study found that ramped-up production of Tph1 helps ILC2s to enter an inflammatory state. This advance may lead to future drugs that could suppress Tph1 in an attempt to alleviate allergic and inflammatory conditions.
WDOM has lost one of its most beloved benefactors, Jill Roberts, who passed away peacefully over the weekend. Jill Roberts was enthusiastically involved in our institutions and committed to improving the lives of those with IBD.
The study has yielded breakthroughs to help illuminate a growing body of evidence that gut microbial metabolites play a critical role in mucosal immunity and inflammation.
The paper opens a new window on the control of blood glucose levels through the liver via gut microbiome.
Results of a recent study that used a new drug combination (glecaprevir/pibrentasivr) for chronic HCV and compensated cirrhosis of the liver, showed high virological cure rates.
The award will fund Dr. Guo's research into how hundreds of different bacterial species living in the human gut contribute to human health and disease.